Your session is about to expire
← Back to Search
Study Summary
This trial will test a new drug to help people with moderate to severe eczema, to see how safe and effective it is.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 18 and 65 years old and in good health.I have had moderate to severe atopic dermatitis for at least 6 months.Your skin condition score is 16 or higher at the initial screening and at the time of randomization.Topical treatments for my skin condition were ineffective or not recommended for me.My skin condition affects more than 10% of my body.Your vIGA AD score is 3 or higher during screening and randomization.I cannot tolerate drugs given under the skin.I haven't used a tanning booth or had long sun exposure in the last 4 weeks.I have a condition that weakens my immune system.
- Group 1: ANB032 SC Dose 1
- Group 2: ANB032 SC Dose 2
- Group 3: ANB032 SC Dose 3
- Group 4: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the enrollment criteria for this experiment including those over eighty-five years of age?
"This clinical trial has set 18 as the lower limit of age eligibility and 65 as its upper cap."
How many participants can the current research accommodate?
"Indeed, the clinicaltrials.gov website provides evidence that this trial is still actively recruiting individuals, having initially been posted on June 13th 2023 and recently updated on July 5th 2023. The recruitment necessitates 160 patients from 28 distinct sites."
Could I potentially be admitted into this experiment?
"The criteria for acceptance into this clinical trial requires that participants have atopic dermatitis and are between 18-65 years of age. This medical study is actively recruiting a total of 160 individuals."
Is this scientific experiment recruiting participants at the present time?
"Affirmative. The clinical trial details published on clinicaltrials.gov suggest that this medical study, which was posted in June of 2023 and last updated in July, is actively searching for participants. 160 patients need to be enrolled from 28 different sites."
Has ANB032 SC Dose 1 successfully passed regulatory scrutiny from the FDA?
"Our assessment of ANB032 SC Dose 1's safety is a 2 due to the lack of clinical data supporting its efficacy, though there are numerous reports that suggest it is secure."
How many research sites are administering this experiment?
"Patients can join this medical trial at Center For Dermatology Clinical Research Inc. in Fremont, Florida, Antelope Valley Clinical Trials in Lancaster, Georgia, and Torrance Clinical Research Institute Inc. in Lomita Kentucky as well as 28 additional sites around the country."
Share this study with friends
Copy Link
Messenger